INS and Insulin resistance: In this context, a plausible explanation for the association observed in the present study could be that patients with higher baseline weight and, thus, a higher degree of insulin resistance tend to insufficiently stimulate insulin secretion after GLP-1 RA therapy and, therefore, exhibit poor response to treatment [35].